Ipsen goes back to black | PharmaBoardroom
written on 28.02.2014

Ipsen goes back to black


The firm booked a consolidated net profit of €153m after suffering a loss of €27.5m in 2012. The firm also exceeded its operating margin target by one percentage point to hit 17% on a recurring basis, adjusted for one-off items.

Latest Report